Hyundai Pharmaceutical Co Ltd
KRX:004310
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hyundai Pharmaceutical Co Ltd
KRX:004310
|
KR |
|
D
|
Deutsche Bank AG
F:DBK
|
DE |
Dividends
Dividend Yield
Hyundai Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Hyundai Pharmaceutical Co Ltd
Hyundai Pharmaceutical Co Ltd have increased by 41%.
Payout Ratio
Hyundai Pharmaceutical Co Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
Hyundai Pharmaceutical Co Ltd is
.
Peers Comparison
Shareholder Yield
Price Appreciation
Price
Hyundai Pharmaceutical Co Ltd
| Average Annual Return | 19.14% |
| Standard Deviation of Annual Returns | 66.82% |
| Max Drawdown | -68% |
| Market Capitalization | 273.9B KRW |
| Shares Outstanding | 32 000 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Hyundai Pharmaceutical Co Ltd's latest stock split occurred on Oct 20, 2017
The company executed a 1816-for-1769 stock split, meaning that for every 1769 shares held, investors received 1816 new shares.
Before the split, Hyundai Pharmaceutical Co Ltd traded at 3669.9989 per share. Afterward, the share price was about 3387.0947.
The adjusted shares began trading on Oct 20, 2017. This was stock split number 11 in Hyundai Pharmaceutical Co Ltd's history, following the previous one in Mar 17, 2008.